PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Rockwell Medical, Inc. (RMTI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US7743741024

CUSIP

774374102

Sector

Healthcare

IPO Date

Jan 27, 1998

Highlights

Market Cap

$59.79M

EPS (TTM)

-$0.04

PEG Ratio

-0.79

Total Revenue (TTM)

$76.82M

Gross Profit (TTM)

$13.85M

EBITDA (TTM)

$2.88M

Year Range

$1.23 - $5.15

Target Price

$6.50

Short %

1.57%

Short Ratio

1.81

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
RMTI vs. VOO
Popular comparisons:
RMTI vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Rockwell Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
-40.36%
9.31%
RMTI (Rockwell Medical, Inc.)
Benchmark (^GSPC)

Returns By Period

Rockwell Medical, Inc. had a return of -9.31% year-to-date (YTD) and 38.06% in the last 12 months. Over the past 10 years, Rockwell Medical, Inc. had an annualized return of -34.07%, while the S&P 500 had an annualized return of 11.31%, indicating that Rockwell Medical, Inc. did not perform as well as the benchmark.


RMTI

YTD

-9.31%

1M

-12.74%

6M

-40.32%

1Y

38.06%

5Y*

-44.65%

10Y*

-34.07%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of RMTI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.00%-9.31%
2024-30.16%6.82%17.73%-12.05%20.21%0.28%3.98%56.28%38.81%-8.06%-37.26%-10.92%7.94%
202346.80%10.07%10.37%52.49%20.29%64.46%-34.62%-34.73%-10.73%-14.42%0.28%5.88%86.21%
20220.29%-18.04%39.85%-30.41%-54.55%-21.34%10.08%27.46%-27.07%-26.01%11.60%-6.88%-77.49%
202118.81%12.50%-14.07%-16.84%-9.80%4.60%-19.79%-9.04%-10.24%-10.00%-20.77%-3.53%-59.41%
20206.97%7.66%-27.05%13.66%-8.15%-8.88%-11.79%-23.84%-18.32%-20.34%23.18%-3.81%-58.61%
201938.05%49.04%22.37%-15.47%-4.37%-34.57%-11.63%-3.76%7.81%-19.93%3.17%7.02%7.96%
2018-4.21%4.57%-10.63%1.54%1.70%-8.36%-17.65%20.94%-14.05%-3.32%-18.87%-31.72%-61.17%
2017-11.30%2.24%5.39%37.38%-16.74%10.75%-10.09%-11.36%35.44%-29.21%1.16%-5.06%-11.15%
2016-38.87%53.35%-21.77%23.17%3.68%-21.06%6.34%-9.81%-7.71%-13.28%11.88%0.77%-36.04%
20154.96%-7.32%9.30%-11.16%14.01%45.62%-14.39%-13.26%-35.59%50.19%4.75%-15.58%-0.39%
2014-1.72%23.68%-0.24%-19.75%10.83%6.48%-15.76%-5.54%-4.19%-4.60%2.64%14.86%-1.53%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RMTI is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RMTI is 6262
Overall Rank
The Sharpe Ratio Rank of RMTI is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of RMTI is 6262
Sortino Ratio Rank
The Omega Ratio Rank of RMTI is 6565
Omega Ratio Rank
The Calmar Ratio Rank of RMTI is 6161
Calmar Ratio Rank
The Martin Ratio Rank of RMTI is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Rockwell Medical, Inc. (RMTI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for RMTI, currently valued at 0.42, compared to the broader market-2.000.002.000.431.74
The chart of Sortino ratio for RMTI, currently valued at 1.13, compared to the broader market-4.00-2.000.002.004.006.001.132.35
The chart of Omega ratio for RMTI, currently valued at 1.17, compared to the broader market0.501.001.502.001.171.32
The chart of Calmar ratio for RMTI, currently valued at 0.33, compared to the broader market0.002.004.006.000.332.61
The chart of Martin ratio for RMTI, currently valued at 1.14, compared to the broader market0.0010.0020.0030.001.1410.66
RMTI
^GSPC

The current Rockwell Medical, Inc. Sharpe ratio is 0.43. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Rockwell Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50SeptemberOctoberNovemberDecember2025February
0.43
1.74
RMTI (Rockwell Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Rockwell Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.10%
0
RMTI (Rockwell Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Rockwell Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Rockwell Medical, Inc. was 99.59%, occurring on Nov 9, 2022. The portfolio has not yet recovered.

The current Rockwell Medical, Inc. drawdown is 99.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.59%Jul 17, 20151842Nov 9, 2022
-92.86%Mar 14, 2000231Feb 23, 20011235Feb 27, 20061466
-83.66%Mar 30, 2006662Nov 12, 2008185Aug 10, 2009847
-80.3%Jun 14, 2011444Mar 20, 2013570Jun 24, 20151014
-76.83%Jan 30, 199876May 20, 1998446Mar 13, 2000522

Volatility

Volatility Chart

The current Rockwell Medical, Inc. volatility is 12.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
12.66%
3.07%
RMTI (Rockwell Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Rockwell Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Rockwell Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab